Hamel Keith M, Mandal Malay, Karki Sophiya, Clark Marcus R
Department of Medicine, Section of Rheumatology, Gwen Knapp Center for Lupus and Immunology Research, The University of Chicago , Chicago, IL , USA.
Front Immunol. 2014 Apr 2;5:139. doi: 10.3389/fimmu.2014.00139. eCollection 2014.
The essential events of B-cell development are the stochastic and sequential rearrangement of immunoglobulin heavy (Igμ) and then light chain (Igκ followed by Igλ) loci. The counterpoint to recombination is proliferation, which both maintains populations of pro-B cells undergoing Igμ recombination and expands the pool of pre-B cells expressing the Igμ protein available for subsequent Igκ recombination. Proliferation and recombination must be segregated into distinct and mutually exclusive developmental stages. Failure to do so risks aberrant gene translocation and leukemic transformation. Recent studies have demonstrated that proliferation and recombination are each affected by different and antagonistic receptors. The IL-7 receptor drives proliferation while the pre-B-cell antigen receptor, which contains Igμ and surrogate light chain, enhances Igκ accessibility and recombination. Remarkably, the principal downstream proliferative effectors of the IL-7R, STAT5 and cyclin D3, directly repress Igκ accessibility through very divergent yet complementary mechanisms. Conversely, the pre-B-cell receptor represses cyclin D3 leading to cell cycle exit and enhanced Igκ accessibility. These studies reveal how cell fate decisions can be directed and reinforced at each developmental transition by single receptors. Furthermore, they identify novel mechanisms of Igκ repression that have implications for gene regulation in general.
B细胞发育的基本事件是免疫球蛋白重链(Igμ),随后是轻链(先Igκ后Igλ)基因座的随机且有序重排。与重排相对的是增殖,增殖既能维持正在进行Igμ重排的前B细胞群体,又能扩大表达可用于后续Igκ重排的Igμ蛋白的前B细胞库。增殖和重排必须被分隔到不同且相互排斥的发育阶段。否则就有基因异常易位和白血病转化的风险。最近的研究表明,增殖和重排分别受不同且相互拮抗的受体影响。IL-7受体驱动增殖,而包含Igμ和替代轻链的前B细胞抗原受体则增强Igκ的可及性和重排。值得注意的是,IL-7R的主要下游增殖效应分子STAT5和细胞周期蛋白D3,通过非常不同但互补的机制直接抑制Igκ的可及性。相反,前B细胞受体抑制细胞周期蛋白D3,导致细胞退出细胞周期并增强Igκ的可及性。这些研究揭示了细胞命运决定如何在每个发育转变中由单个受体引导和强化。此外,它们还确定了Igκ抑制的新机制,这对一般的基因调控具有重要意义。